| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001546 | Preantral ovarian follicle growth | Increases phenotype | PMID:29146461 |
| GO:0006582 | Melanin metabolic process | Affects phenotype | PMID:34856342 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:28289825; PMID:34856342 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:27709270; PMID:29975444 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:27709270 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:27709270 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:29680209 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:31676321 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:33836606 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:28289825 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Increases phenotype | PMID:31626383 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:25431849; PMID:28289825 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25431849 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:27697457; PMID:30779469 |
| GO:0032620 | Interleukin-17 production | Increases phenotype | PMID:25203682 |
| GO:0032626 | Interleukin-22 production | Increases phenotype | PMID:25203682 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:25431849 |
| GO:0042178 | Xenobiotic catabolic process | Decreases phenotype | PMID:26535918 |
| GO:0043029 | T cell homeostasis | Affects phenotype | PMID:34036678 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:25431849 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:34856342 |
| GO:0045618 | Positive regulation of keratinocyte differentiation | Increases phenotype | PMID:27869817 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:27709270 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:27709270 |
| GO:0060402 | Calcium ion transport into cytosol | Increases phenotype | PMID:27709270 |
| GO:0071483 | Cellular response to blue light | Increases phenotype | PMID:25431849 |
| GO:0071492 | Cellular response to uv-a | Affects phenotype | PMID:25431849 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:34856342 |
| GO:0090200 | Positive regulation of release of cytochrome c from mitochondria | Increases phenotype | PMID:28289825 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:25431849 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27709270 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28289825 |
| GO:2000321 | Positive regulation of t-helper 17 cell differentiation | Increases phenotype | PMID:25716673 |
| GO:2000330 | Positive regulation of t-helper 17 cell lineage commitment | Increases phenotype | PMID:30611761 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.